39results about How to "Improve systemic symptoms" patented technology

The invention relates to a medical preparation, in particular to a medicine composition for relieving eyestrain. The effective constituents of the composition are composed of, by weight, 0.01 part to 0.3 part of oviductus ranae, 0.01 part to 0.03 part of xanthin, 0.01 part to 0.03 part of vitamin A, and 1 part to 5 parts of water extract containing fructus lycii, folium mori, semen cassiae, blueberries and Cassia tora, wherein the weight of fructus lycii, the weight of folium mori, the weight of semen cassiae, the weight of the blueberries and the weight of Cassia tora are the same. The composition can resist eyestrain and is suitable for people with computer eyestrain syndromes, VDT eyestrain, computer vision syndromes, computer terminal syndromes, eyestrain and the like.

The invention discloses an application of remdesivir in preparation of a medicine for treating novel coronavirus (2019-nCoV). A remdesivir preparation can effectively improve respiratory distress, cough, expectoration, fever and other systemic symptoms of patients infected with the novel coronavirus (2019-nCoV), delay disease progression and improve the life quality of the patients, and has wide application value. The preparation which is relatively good in product stability and is used for preventing and treating the novel coronavirus is obtained through drug research and determination.

The Chinese medicine composition for treating coronary heart disease is prepared with 14 kinds of Chinese medicinal materials, including dalbergia wood, sandalwood, Chuanxiong rhizome, angelica, notoginseng, etc. It may be bolus, capsule, tablet or granule. The medicine of present invention has the advantages of high curative effect and less recurrence.

The invention discloses a medicament, particularly a medicament for treating hyperpiesis and preventing complications. The medicament for treating the hyperpiesis and preventing the complications is characterized in that the medicament is prepared from the following components in portion by weight: 2 to 3 portions of silybum marianum, 1 to 2 portions of merremia hungaiensis, 3 to 4 portions of radix astragali, 1 to 2 portions of tuber of dwarf lilyturf, 1 to 2 portions of tuckahoe, 1 to 2 portions of almond, 1 to 2 portions of angelica, 2 to 3 portions of dark plum fruit, 2 to 3 portions of rehmannia root, 3 to 5 portions of radix salviae miltiorrhizae, 2 to 3 portions of herba schizonepetae, 3 to 4 portions of aster ageratoides, 3 to 5 portions of schisandraceae, 2 to 3 portions of raw lacquer, 3 to 4 portions of apocynum, 3 to 4 portions of cactus, 2 to 3 portions of mistletoe, and 2 to 3 portions of large-head atractylodes rhizome. The medicament improves the symptoms of the whole body by adjusting yin and yang, qi and blood of the body, achieves the effect of reducing pressure, has remarkable treatment effect, and improves the life quality of patients. The Chinese medicament has good treatment effect and quick response and has no side effect, and the effective rate reaches 95.9 percent.

A dermal agent for preventing or treating acne, comprising an ascorbic acid derivative which liberates in vivo ascorbic acid, and a zinc salt or comprising a zinc salt of the ascorbic acid-2-phosphate, and a composition comprising tretinoin and an ascorbic acid derivative or a salt thereof, relieving in the irritation of tretinoin by using the dermal agent and tretinoin in combination.

The invention relates to asthenopia-relieving composition containing L-theanine, gamma-aminobutyric acid and procyanidine, and belongs to the fields of medicine and health. The asthenopia-relieving composition contains L-theanine, gamma-aminobutyric acid and procyanidine as active components. Population trial results prove that the composition not only treats local symptoms of eyes with asthenopia, but also can obviously improve general symptoms, such as inattention, memory deterioration and the like, caused by different degrees of asthenopia, has remarkable asthenopia relieving effect and hasbroad market prospect.

The invention relates to a medicament for treating colitis, which belongs to traditional Chinese medical powders for treating chronic colitis. The invention provides a traditional Chinese medicament with reliable effects, wide indication, no side effects and low price to solve the problems of not ideal curative effects and high recurrence rate of the existing medicaments for treating chronic colitis. The components of the medicament are as follows: astragalus: 80 to 120g, glycyrrhiza: 30 to 40g, white peony roots: 30 to 40g, aokai: 20 to 30g, zhebei: 20 to 30g, cuttlebone:30 to 40g, poria: 30 to 40g, and prepared rhizoma corydalis: 30 to 40g.

The invention relates to a composition containing theanine, gamma-aminobutyric acid and astaxanthin for relieving asthenopia, and belongs to the field of medical health. The composition for relievingthe asthenopia is prepared from the active ingredients of theanine, gamma-aminobutyric acid and astaxanthin. Proofed by trial results of users, the composition has the advantages that the local symptom of eyes with asthenopia is solved, the psychosomatic manifestations due to different degrees of asthenopia can be more obviously relieved, such as unconcentrated attention and decreased memory, theeffect of relieving the asthenopia is obvious, and the market prospect is broad.

The invention belongs to the technical field of hygienic products, and particularly relates to a preparation method of a side-leakage-preventing antibacterial sanitary towel. The towel comprises a skin-friendly layer, a flow guide layer, a cotton core layer and a supporting layer which are sequentially compounded from top to bottom, wherein protective wings used for preventing side leakage are further arranged on the two sides of the supporting layer; a nursing layer is further arranged between the skin-friendly layer and the flow guide layer, and is formed by soaking a non-woven fabric in sanitary towel fluff pulp uniformly adsorbing a mixed medicament and then taking out and drying the non-woven fabric; and the mixed medicament is prepared by mixing the following raw materials in parts by weight of 6-10 parts of a tea leaf extract, 10-14 parts of a fruit peel extract, 3-5 parts of a pulp extract and 6-12 parts of a Chinese herbal medicine extract. According to the invention, the shelf life of the sanitary towel can be effectively prolonged, and meanwhile the prepared sanitary towel has the effects of sterilization and disinfection. Compared with existing similar sanitary towels, the sanitary towel has the advantages that the advantages of no drug resistance, natural drug application and the like of the similar sanitary towels are reserved, the original performance and processing technology of the sanitary towel are not changed, and the sanitary towel has practical production significance and value.

A Chinese medicine for treating hypertension and preventing cerebral hemorrhage, apoplexy and coronary heart disease is prepared from 20 Chinese-medicinal materials including astragalus root, cinnamon twig, white peony root, red sage root, etc.

A Chinese medicine in the form of pill for making eye muscle stronger, nourishing kidney, preventing retrograde lesion of eye, improving vision, etc is prepared from 18 Chinese-medicinal materials including the eyeball of ox, horse, donkey, etc, rehmannia root, yam, cordyceps, etc.

The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicinal composition for treating hormone refractory prostate cancer. Every dosage of the traditional Chinese medicine consists of the following traditional Chinese medicinal materials by weight: 15-25g of royal jelly, 15-25g of pollen pini, 6-14g of honey, 80-120ml of goose blood and 6-14g of ginseng. The traditional Chinese medicinal composition is used for treating hormone refractory prostate cancer; and an effective rate of treating for three months reaches 85%.

The invention relates to a composition containing theanine, phosphatidylserine and procyanidine for relieving visual fatigue, and belongs to the field of medicine and health. The invention provides the composition for relieving visual fatigue, which is prepared from the active ingredients: the theanine, the phosphatidylserine and the procyanidine. The test result shows that the composition provided by the invention not only aims at visual fatigue eye local symptoms but also can remarkably improve constitutional symptoms such as inattention and memory deterioration caused by different degrees of visual fatigue, the composition has a remarkable effect on relieving visual fatigue, and has a broad market prospect.

The invention relates to an external medicine for treating psoriasis. The external medicine is characterized in that the effective ingredient of the external medicine is prepared from the following compositions in weight portion: 10 to 60 grams of glabrous greenbrier rhizome, 5 to 60 grams of realgar, 0.5 to 15 grams of hydrargyri subchloridum, 5 to 30 grams of angelica, 10 to 60 grams of white alum, 10 to 60 grams of gypsum, 5 to 30 grams of calamine, 10 to 60 grams of leaching monoxide, 10 to 60 grams of morel, 0.5 to 10 grams of borneol, 50 to 200 grams of mirabilite and 5 to 60 grams of ceruse. The external medicine has the advantages that through the synergism of compositions, the medicine has the functions of fully clearing away heat and toxic materials, using poisons as antidotes, eliminating dampness, relieving itching, drying dampness, killing parasites, eliminating inflammation and swellings, cooling and relieving blood, reliving pain and rehabilitating skin function, and is an effective external medicine for treating psoriasis; the effective rate reaches 100 percent; the healing rate reaches 95 percent; and the effect developing rate is 87.5 percent.

The present invention relates to medicine, and is especially one kind of hypertension treating Chinese medicine composition. The Chinese medicine composition is prepared with mint, borneol, astragalus root, angelica, Chuanxiong rhizome and other 13 kinds of Chinese medicinal materials in certain weight proportion. The Chinese medicine composition of the present invention regulates body's Yin-Yang, vital energy and blood to improve systemic symptoms so as to lower blood pressure. It has obvious curative effect, fast acting and no side effect.

The invention discloses a traditional Chinese medicine preparation for treating postpartum hypogalactia, which comprises the following active ingredients by weight: 30-50g ricepaperplant pith, 20-30g Chinese angelica, 10-20g akebiaquinata, 10-20g stir-baked squama manitis, 10-20g uniflower swisscentaury root, 10-20g roasted cowherb seed, 10-20g radices trichosanthis, 10-20g platycodon grandiflorum, 10-20g ginseng, 8-15g dandelion, 8-12g radix paeoniae alba, 8-12g astragalus mongholicus, 8-12g radix ophiopogonis, 8-12g charred schizonepeta spike, 8-12g ginger carbo, and 8-12g raw malt. The active ingredients are excellent in compatibility, and exert effects of soothing a liver, resolving depression, tonifying qi, nourishing yin, tonifying blood, promoting blood circulation, restoring menstrual flow and promoting lactation. The traditional Chinese medicine preparation for treating the postpartum hypogalactia is definite in curative effect and high in cure rate, has no side effect, and is worthy of clinical popularization and application.

The invention relates to compositions used for regulating functions of ovary. The compositions used for regulating the functions of the ovary take tortoiseshell as a monarch drug and sea horse and lily as ministerial drugs; then characteristics of female patients in different ages are combined, according to the condition of the female patients, ovary hypofunction is classified into three stages, namely kidney qi deficiency, kidney yin deficiency and internal thermal, deficiency of liver-yin and kidney-yin as well as heart-kidney imbalance; medicinal materials are selected and applied according to the ages of the patients and the condition of the patients in clinic. The compositions provided by the invention start from a viewpoint of 'life network regulation', according to physiological and pathological characteristics of women in different ages, a principle of syndrome differentiation is adopted, a conditioning formula applicable to 'women of 30 years old', 'women of 40 years old' and 'women of 50 years old' is summarized, and ovary functions of the women in the three age groups are adjusted, so that ovary functions of the patient are improved, and life quality is improved.

The invention discloses a diabetes functional beverage gamma balance liquid, belongs to the technical field of food adjunctive therapy, and specifically relates to a functional ecology beverage with significant effects of control of blood glucose and improvement of diabetic complications. The present invention provides a beverage with characteristics of nourishing and relieving by the food, effective control of blood glucose fluctuation, and improvement of symptom complex. According to the present invention, the beverage of the present invention can match the drug treatment, such that the useamount of the drug can be gradually reduced, the side effect can be reduced, the body immunity can be improved, and the symptom complex of the diabetes can be improved; 3000 ml of the diabetes functional beverage of the present invention is prepared by the following components, wherein the components comprise: 200-300 mg of gamma-amino butyric acid (food-grade powder), 3-5 g of ginseng, 5-10 g ofobtuseleaf senna seed, 3-5 g of ganoderma lucidum, 5-10 g of mulberry, 3-5 g of corn stigma, 10-15 g of black bean and the balance of water.

The invention discloses a medicament, particularly a medicament for treating hyperpiesis and preventing complications. The medicament for treating the hyperpiesis and preventing the complications is characterized in that the medicament is prepared from the following components in portion by weight: 2 to 3 portions of silybum marianum, 1 to 2 portions of merremia hungaiensis, 3 to 4 portions of radix astragali, 1 to 2 portions of tuber of dwarf lilyturf, 1 to 2 portions of tuckahoe, 1 to 2 portions of almond, 1 to 2 portions of angelica, 2 to 3 portions of dark plum fruit, 2 to 3 portions of rehmannia root, 3 to 5 portions of radix salviae miltiorrhizae, 2 to 3 portions of herba schizonepetae, 3 to 4 portions of aster ageratoides, 3 to 5 portions of schisandraceae, 2 to 3 portions of raw lacquer, 3 to 4 portions of apocynum, 3 to 4 portions of cactus, 2 to 3 portions of mistletoe, and 2 to 3 portions of large-head atractylodes rhizome. The medicament improves the symptoms of the whole body by adjusting yin and yang, qi and blood of the body, achieves the effect of reducing pressure, has remarkable treatment effect, and improves the life quality of patients. The Chinese medicament has good treatment effect and quick response and has no side effect, and the effective rate reaches 95.9 percent.

The invention discloses a medicament which belongs to traditional Chinese medicine powder for curing ulcerative colitis, and the invention mainly provides a traditional Chinese medicine which has the advantages of reliable healing efficacy, wide adaptation, no toxic side effect and low cost. The invention adopts the following technical proposal:, the components of the Chinese medicine are as follows: liquorice: 20 to 40 grams, white paeony root: 20 to 40 grams, nacre: 30 to 40 grams, shellfish: 15 to 25 grams and phragmites japonica: 20 to 25 grams.

The present invention relates to intravenous injection for treating cardiovascular system diseases and its preparation process. It is prepared by using red ginseng 20-30 wt%, mankshood 10-15 wt%, Rhizoma Ligustici Chuanxiong 40-60 wt% and rhubarb 10-15 wt% and through alcohol extraction of red ginseng, distillation of Rhizoma Ligustici Chuanxiong, acid and ankali treatment of alcohol extractive liquid of rhubarb, pre-decoction of mankshood, water extraction and alcohol of the other material, mixing of extractive liquid, further acid treatment, and addition of antioxidant and assistant. It is suitable for treating coronary heart disease, myocarditis, rheumatic heart disease, hypertension and other cardiac vascular diseases.

The invention relates to a traditional Chinese medicine composition for treating infertility caused by premature ovarian failure. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 25-35 parts of human placenta, 25-35 parts of amethyst, 10-20 parts of prepared rehmannia root, 10-20 parts of radix paeoniae alba, 7-12 parts of bighead atractylodes rhizome, 14-16 parts of semen cuscutae, 14-16 parts of morinda officinalis, 14-16 parts of cistanche, 14-16 parts of herba epimedii, 8-10 parts of rhizoma curculiginis and 5-7 parts of honey-fried licorice root. The invention further provides application of the traditional Chinese medicine composition. According to the traditional Chinese medicine composition, the reproductive function of infertility patients caused by premature ovarian failure is improved, the total pregnancy rate of a traditional Chinese medicine group is increased compared with that of a DHEA group, and the transplantation success rate is obviously increased. The traditional Chinese medicine composition has the advantages that the traditional Chinese medicine composition is mild in medicine flavor, warm and tonify, both essence and blood are taken into consideration, kidney yang is warmly tonified without losing dryness, the kidney is nourished, the spleen is not cold, cool and greasy, the primary and secondary effects are clear, the compatibility is rigorous, simple and essential effects are achieved, and the effects of warmly tonify kidney yang, tonify spleen, supplement qi, regulate brewing and recuperating eggs are jointly achieved.

The invention discloses a traditional Chinese medicine for treating a spleen deficiency type leukorrhagia. The traditional Chinese medicine is prepared from medicines in parts by weight as follows: 15 parts of acanthopanax obovatus hoo, 30 parts of bilobed grewia, 15 parts of roots of bilobed grewia, 30 parts of common curculigo rhizome, 30 parts of roots of macartney rose, 15 parts of Astragalus tibetanus Benth ex Bunge, 6 parts of katsumade galangal seeds, 30 parts of fortune firethorn fruits, 40 parts of tufted fig roots, 9 parts of shiny bugleweed, 24 parts of ammannia arenaria, 25 parts of Schisandra henryi Clarkevar.yun-nanensis A.C.Smith, 30 parts of Saxifraga takedana Nakai, 30 parts of Astragalus monadelphus Bunge, 15 parts of Chinese red dates, 15 parts of roots of longflower stringbush, 9 parts of meehania henryi and 30 parts of shortleaf podocarpus. The medicines in the formula can cooperate with one another, have a synergistic effect, perform the efficacy of spleen invigorating, qi tonifying and yang invigorating for dampness removal and can effectively treat the spleen deficiency type leukorrhagia; multiple cases of patients in several years show that the effective rate reaches 97.5%.

The invention discloses a drug, particularly a drug for prostate disease. The said drug is characterized in that the drug is formed by the raw medicine of the following weight account, 400-500g of Radix Rehmanniate, 100-155g of Cornus officinalis, 200-260g of Chinese yarn, 100-200g of Rhizoma Alismatis, 100-195g of Poria Cocos, 200-260g of Cortex Moutan, 30-75g of Licorice, 200-260g of Peach Kernel, 20-98g of Epimedium, 20-60g of Chinese chive seed, 100-160g of Rosa laevigata michx, 200-260g of Atractylodes lancea, 100-300g of Hedgehog skin, 300-380g of Schizandra chinensis. The features of the drug comprise good curative effect, quick effect, no side-effect, high heal-up rate, 98% of effective rate.

The invention relates to a traditional Chinese medicine composition for treating nasal and nasosinusitis, a preparation and a preparation method thereof. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 20-40 parts of ephedra, 20-35 parts of Chinese herbaceous peony, 9-15 parts of asarum, 20-50 parts of dried ginger, 25-35 parts of liquorice, 25-40 parts of cassia twig, 15-20 parts of schisandra chinensis, 30-35 parts of pinellia ternate, 18-25 parts of polyporus umbellatus, 18-35 parts of poria cocos, 15-20 parts of bighead atractylodes rhizome, 25-30 parts of rhizoma alismatis, 20-35 parts of magnolia flower and 20-40 parts of cocklebur fruit. The traditional Chinese medicine composition is scientific in formula, has the functions of relieving exterior syndrome, dispelling cold and warming lung to dissipate fluid retention through compounding of the medicines, has the advantages of few side effects, outstanding clinical effects and the like, and can effectively treat nasal and nasosinusitis.

The Chinese medicine composition for treating coronary heart disease is prepared with 14 kinds of Chinese medicinal materials, including dalbergia wood, sandalwood, Chuanxiong rhizome, angelica, notoginseng, etc. It may be bolus, capsule, tablet or granule. The medicine of present invention has the advantages of high curative effect and less recurrence.

The invention discloses a traditional Chinese medicine preparation for treating postpartum hypogalactia, which comprises the following active ingredients by weight: 30-50g ricepaperplant pith, 20-30g Chinese angelica, 10-20g akebiaquinata, 10-20g stir-baked squama manitis, 10-20g uniflower swisscentaury root, 10-20g roasted cowherb seed, 10-20g radices trichosanthis, 10-20g platycodon grandiflorum, 10-20g ginseng, 8-15g dandelion, 8-12g radix paeoniae alba, 8-12g astragalus mongholicus, 8-12g radix ophiopogonis, 8-12g charred schizonepeta spike, 8-12g ginger carbo, and 8-12g raw malt. The active ingredients are excellent in compatibility, and exert effects of soothing a liver, resolving depression, tonifying qi, nourishing yin, tonifying blood, promoting blood circulation, restoring menstrual flow and promoting lactation. The traditional Chinese medicine preparation for treating the postpartum hypogalactia is definite in curative effect and high in cure rate, has no side effect, and is worthy of clinical popularization and application.